FR2100671A1 - - Google Patents

Info

Publication number
FR2100671A1
FR2100671A1 FR7118178A FR7118178A FR2100671A1 FR 2100671 A1 FR2100671 A1 FR 2100671A1 FR 7118178 A FR7118178 A FR 7118178A FR 7118178 A FR7118178 A FR 7118178A FR 2100671 A1 FR2100671 A1 FR 2100671A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7118178A
Other languages
French (fr)
Other versions
FR2100671B1 (cs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH749870A external-priority patent/CH565729A5/xx
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2100671A1 publication Critical patent/FR2100671A1/fr
Application granted granted Critical
Publication of FR2100671B1 publication Critical patent/FR2100671B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/16Benz[e]indenes; Hydrogenated benz[e]indenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7118178A 1970-05-21 1971-05-19 Expired FR2100671B1 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3956070A 1970-05-21 1970-05-21
CH749870A CH565729A5 (cs) 1970-05-21 1970-05-21

Publications (2)

Publication Number Publication Date
FR2100671A1 true FR2100671A1 (cs) 1972-03-24
FR2100671B1 FR2100671B1 (cs) 1974-08-30

Family

ID=25701459

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7118178A Expired FR2100671B1 (cs) 1970-05-21 1971-05-19

Country Status (5)

Country Link
BE (1) BE767348A (cs)
DE (1) DE2123046A1 (cs)
FR (1) FR2100671B1 (cs)
GB (2) GB1336895A (cs)
NL (1) NL7105885A (cs)

Also Published As

Publication number Publication date
NL7105885A (cs) 1971-11-23
DE2123046A1 (de) 1972-01-27
GB1336895A (en) 1973-11-14
GB1336896A (en) 1973-11-14
BE767348A (fr) 1971-11-19
FR2100671B1 (cs) 1974-08-30

Similar Documents

Publication Publication Date Title
AR204384A1 (cs)
ATA96471A (cs)
AU2044470A (cs)
AU1146470A (cs)
AU1473870A (cs)
AU2085370A (cs)
AU1336970A (cs)
AU2130570A (cs)
AU2017870A (cs)
AU1833270A (cs)
AU1716970A (cs)
AU1517670A (cs)
AU1326870A (cs)
AR195465A1 (cs)
AU1591370A (cs)
AU1841070A (cs)
AU1328670A (cs)
AU2144270A (cs)
AU1343870A (cs)
AU1277070A (cs)
AU2131570A (cs)
AU2130770A (cs)
AU1247570A (cs)
AU1581370A (cs)
AU1235770A (cs)

Legal Events

Date Code Title Description
ST Notification of lapse